Overview
Anxiolytic-induced organic mental disorder refers to psychiatric symptoms or disorders that may arise secondary to the use of anxiolytic medications, potentially complicating the management of somatic conditions. While anxiolytics can improve patient well-being in certain somatic disorders, they may also precipitate adverse effects in others.Diagnosis
Monitor for psychiatric symptoms such as anxiety exacerbation or emergence of depressive features 1.
Evaluate clinical context for somatic disorder management alongside psychiatric presentation.
No specific diagnostic tests; clinical judgment and patient history are crucial 1.Management
First-line: Careful consideration of anxiolytic use based on specific somatic condition 1.
Adjunctive: Use benzodiazepines cautiously, particularly in acute respiratory conditions 1.
Avoid: Benzodiazepines in hypertension without clear benefit and potential for harm 1.
Plan: Treatment with a clear strategy for tapering and discontinuation 1.Special Populations
Elderly: Use benzodiazepines with extreme caution due to increased risk of adverse effects 1.
Comorbidities: Exercise caution in patients with respiratory conditions; avoid in acute exacerbations 1.Key Recommendations
Evaluate the necessity of anxiolytic therapy on a case-by-case basis for somatic disorders, considering potential benefits and risks 1 (Evidence: Moderate).
Use benzodiazepines cautiously, especially in patients with respiratory conditions or hypertension, due to possible adverse outcomes 1 (Evidence: Moderate).
Plan for the eventual discontinuation of anxiolytic therapy to mitigate long-term dependency and side effects 1 (Evidence: Expert opinion).References
1 Krogh C, McLean WM, LaPierre YD. Minor tranquillizers in somatic disorders. Canadian Medical Association journal 1978. link